130 related articles for article (PubMed ID: 19213955)
1. Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditis.
Marchant D; Dou Y; Luo H; Garmaroudi FS; McDonough JE; Si X; Walker E; Luo Z; Arner A; Hegele RG; Laher I; McManus BM
Circ Res; 2009 Mar; 104(6):813-21. PubMed ID: 19213955
[TBL] [Abstract][Full Text] [Related]
2. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
3. The protective role of microRNA-21 against coxsackievirus B3 infection through targeting the MAP2K3/P38 MAPK signaling pathway.
He F; Xiao Z; Yao H; Li S; Feng M; Wang W; Liu Z; Liu Z; Wu J
J Transl Med; 2019 Oct; 17(1):335. PubMed ID: 31585536
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B3 infection compromises endothelial-dependent vasodilation of coronary resistance arteries.
Choy JC; Lui AH; Moien-Afshari F; Wei K; Yanagawa B; McManus BM; Laher I
J Cardiovasc Pharmacol; 2004 Jan; 43(1):39-47. PubMed ID: 14668566
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
6. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
Gao G; Zhang J; Si X; Wong J; Cheung C; McManus B; Luo H
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H401-8. PubMed ID: 18515649
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
10. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
[TBL] [Abstract][Full Text] [Related]
11. Contribution of endothelin-1 to myocardial injury in a murine model of myocarditis: acute effects of bosentan, an endothelin receptor antagonist.
Ono K; Matsumori A; Shioi T; Furukawa Y; Sasayama S
Circulation; 1999 Oct; 100(17):1823-9. PubMed ID: 10534471
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis.
Cai Z; Shen L; Ma H; Yang J; Yang D; Chen H; Wei J; Lu Q; Wang DW; Xiang M; Wang J
Circ Heart Fail; 2015 Jul; 8(4):809-18. PubMed ID: 25985795
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of coagulation factor Xa improves myocardial function during CVB3-induced myocarditis.
Malz R; Weithauser A; Tschöpe C; Schultheiss HP; Rauch U
Cardiovasc Ther; 2014 Jun; 32(3):113-9. PubMed ID: 24533719
[TBL] [Abstract][Full Text] [Related]
15. Berberine Restricts Coxsackievirus B Type 3 Replication via Inhibition of c-Jun N-Terminal Kinase (JNK) and p38 MAPK Activation In Vitro.
Dai Q; Zhang D; Yu H; Xie W; Xin R; Wang L; Xu X; He X; Xiong J; Sheng H; Zhang L; Zhang K; Hu X
Med Sci Monit; 2017 Mar; 23():1448-1455. PubMed ID: 28341822
[TBL] [Abstract][Full Text] [Related]
16. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice.
Jiang Y; Zhu Y; Mu Q; Luo H; Zhi Y; Shen X
Antiviral Res; 2017 May; 141():133-139. PubMed ID: 28115196
[TBL] [Abstract][Full Text] [Related]
17.
Fu Q; Gao L; Fu X; Meng Q; Lu Z
J Microbiol Biotechnol; 2019 Aug; 29(8):1230-1239. PubMed ID: 31370111
[No Abstract] [Full Text] [Related]
18.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
19. Stress-activated protein kinases are involved in coxsackievirus B3 viral progeny release.
Si X; Luo H; Morgan A; Zhang J; Wong J; Yuan J; Esfandiarei M; Gao G; Cheung C; McManus BM
J Virol; 2005 Nov; 79(22):13875-81. PubMed ID: 16254323
[TBL] [Abstract][Full Text] [Related]
20. Enhanced ERK-1/2 activation in mice susceptible to coxsackievirus-induced myocarditis.
Opavsky MA; Martino T; Rabinovitch M; Penninger J; Richardson C; Petric M; Trinidad C; Butcher L; Chan J; Liu PP
J Clin Invest; 2002 Jun; 109(12):1561-9. PubMed ID: 12070303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
